NCT02522221View on ClinicalTrials.gov

Tecarfarin Anti-Coagulation Trial (TACT)

PHASE3UnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

March 30, 2019

Study Completion Date

July 1, 2019

Conditions
ThromboembolismThrombosis
Interventions
DRUG

Warfarin

Warfarin is an oral vitamin K antagonist anticoagulant.

DRUG

tecarfarin

Tecarfarin is an oral vitamin K antagonist anticoagulant

Sponsors

Lead Sponsor

Espero Biopharma
All Listed Sponsors
lead

Espero Biopharma

INDUSTRY